Zura Bio Ltd 8-K

What Happened
Zura Bio Ltd (NASDAQ: ZURA) announced on February 11, 2026 that it furnished an updated corporate presentation for use at upcoming conferences and investor meetings. The company filed this disclosure under Item 7.01 (Regulation FD Disclosure) and furnished the presentation as Exhibit 99.1 to the Form 8-K; the presentation is also posted in the “News & Events” section of investors.zurabio.com.

Key Details

• Filing date: February 11, 2026 (Form 8-K, Item 7.01).
• Exhibit: 99.1 — Corporate Presentation dated February 11, 2026.
• Purpose: Updated materials for upcoming conferences and investor meetings.
• Accessibility: Presentation available on Zura Bio’s investor website and attached to the SEC filing; Inline XBRL cover page (Exhibit 104) also included.

Why It Matters
This is a routine Regulation FD disclosure that makes the company’s latest investor presentation publicly available; it does not report earnings, revenue, executive changes (CEO/CFO), mergers, or other material financial results. Investors should review the furnished presentation for any updates on strategy, pipeline, milestones, or timelines that could affect valuation or near-term expectations, and refer to the SEC exhibit or the company website for the full slide deck.